MALCOLM JAN 4

What Happened Malcolm Jan, a director of United Therapeutics Corporation (UTHR), sold 45 shares on 2026-03-17 at $533.51 per share, for gross proceeds of $24,008. This was a sale (not a purchase), which is often routine rather than a direct bullish or bearish signal.

Key Details

• Transaction date and price: 2026-03-17 — 45 shares at $533.51 each.
• Total value: Approximately $24,008 (gross proceeds).
• Shares owned after transaction: Not disclosed in the supplied filing.
• Footnote: The sale was made pursuant to a Rule 10b5-1 trading plan established by the reporting person on September 11, 2025.
• Filing timeliness: Reported on 2026-03-17 (same date as the transaction), indicating a timely filing.

Context A Rule 10b5-1 plan allows insiders to sell pre-scheduled amounts at set times and is commonly used to avoid concerns about trading on material nonpublic information. Such prearranged sales are typically viewed as routine and do not necessarily reflect the insider’s current view of the company’s prospects.